4.2 Article

Folic Acid-Polyethyleneimine Functionalized Mesoporous Silica Nanoparticles as a Controlled Release Nanocarrier

Journal

JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
Volume 19, Issue 10, Pages 6217-6224

Publisher

AMER SCIENTIFIC PUBLISHERS
DOI: 10.1166/jnn.2019.17054

Keywords

Folic Acid-Polyethyleneimine; Mesoporous Silica; pH-Responsive; Controlled Delivery; Cancer Therapy

Funding

  1. National Research Foundation of Korea (NRF) - Ministry of Science and ICT, Korea {Mid-Career Researchers Program} [NRF-2017R1A2B3012961]
  2. National Research Foundation of Korea (NRF) - Ministry of Science and ICT, Korea {Individual Basic Research Program} [NRF-2017R1D1AB03034414]
  3. National Research Foundation of Korea (NRF) - Ministry of Science and ICT, Korea {Brain Korea 21 Plus Program} [21A2013800002]

Ask authors/readers for more resources

In an effort to develop a biocompatible, cancer-targetable, controllable carrier for use in smart delivery systems, including drug delivery, this study designed a novel polymer-mesoporous silica nanoparticle hybrid material functionalized with dicarboxylic acid-modified MCM-41 (DA-MCM-41) and branched polyethylenimine (PEI). First, mesoporous silica nanoparticles (MSNs) were coated with a folic acid (FA)-PEI layer; MCM-41 was prepared by a sol-gel process and diacid-functionalized MCM-41 was prepared by post-modification. Subsequently, DA-MCM-41 was coated with FA grafted PEI via an electrostatic interaction. The cellular uptake of DA-MCM-41 and the FA-PEI layered MSNs by MCF-7 cells was evaluated using dansyl labeled methylene blue (MB). The FA-PEI-functionalized MSNs exhibited higher cellular uptake to MCF-7 cells than DA-MCM-41. This novel nanocarrier was internalized into the targeted tumor cells site-specifically by FA-mediated internalization and the pH-responsive release of guest molecules (here, methylene blue) was realized by an electrostatic interaction between FA-PEI and DA-MCM-41. Overall, FA-PEI-functionalized MSNs may have potential applications in the targeted and controlled delivery of guest molecules for cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available